SUSAN MAY: Open Payments
NPI 1467173013 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 57 payments from 11 companies in 2025. Trend: 2023 $161 · 2024 $378 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $266 |
| Medtronic, Inc. | 3 | $182 |
| Vanda Pharmaceuticals Inc. | 8 | $162 |
| ABBVIE INC. | 17 | $161 |
| Astellas Pharma US Inc | 4 | $84 |
| Exact Sciences Corporation | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: CAPLYTA, MINIMED 780G, VRAYLAR, HETLIOZ, Veozah, Cologuard Collection Kit, Auvelity, Kerendia.
Industry payments across KY — which companies pay providers there.
